Beyond acting as a tumor suppressor during HCC development, ASGR1 expression on circulating cells may serve as an effective liquid biopsy marker for early screening, risk stratification, and treatment monitoring. This evidence concerns the gene ASGR1 and hepatocellular carcinoma.